Tivantinib in combination with Carboplatin and Pemetrexed as first line treatment in patients with advanced non-squamous NSCLC or Malignant Pleural Mesothelioma: results of phase I trial

被引：0
|
作者：
Zucali, P. A. [1 ]
Simonelli, M. [1 ]
De Vincenzo, F. [1 ]
Fatuzzo, G. [1 ]
Bertossi, M. [1 ]
Perrino, M. [1 ]
Miggiano, C. [1 ]
Giordano, L. [1 ]
Bonifacio, C. [1 ]
Sposta, F. Mrakic [1 ]
Santoro, A. [1 ]
机构：
[1] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H18
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [31] Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial
    Ceresoli, Giovanni L.
    Aerts, Joachim G.
    Dziadziuszko, Rafal
    Ramlau, Rodryg
    Cedres, Susana
    van Meerbeeck, Jan P.
    Mencoboni, Manlio
    Planchard, David
    Chella, Antonio
    Crino, Lucio
    Krzakowski, Maciej
    Russel, Jorn
    Maconi, Antonio
    Gianoncelli, Letizia
    Grosso, Federica
    LANCET ONCOLOGY, 2019, 20 (12): : 1702 - 1709
  • [32] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary results
    Patel, J. D.
    Hensing, T. A.
    Villafor, V.
    Hart, E.
    Bonomi, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] FINAL RESULTS OF CTONG 0806: A PHASE II TRIAL COMPARING PEMETREXED WITH GEFITINIB AS SECOND-LINE TREATMENT OF ADVANCED NON-SQUAMOUS NSCLC PATIENTS WITH WILD-TYPE EGFR
    Zhou, Qing
    Cheng, Ying
    Zhao, Ming-Fang
    Yang, Jin-Ji
    Yan, Hong-Hong
    Zhang, Li
    Song, Yong
    Chen, Jian-Hua
    Feng, Wei-Neng
    Xu, Chong-Rui
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S194 - S195
  • [34] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
    Zucali, P. A.
    Ceresoli, G. L.
    Favaretto, A. G.
    Cortinovis, D.
    Grossi, F.
    Marangolo, M.
    Del Conte, G.
    Ceribelli, A.
    Bearz, A.
    Parra, H. Soto
    Santoro, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 28 - 28
  • [35] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
    Parra, HS
    Zucali, R
    Favaretto, A
    Grossi, F
    Fusi, A
    Marangolo, M
    Del Conte, G
    Ceribelli, A
    Bearz, A
    Ceresoli, G
    LUNG CANCER, 2005, 49 : S229 - S229
  • [36] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [37] Phase II trial of carboplatin and pemetrexed combination in elderly patients with advanced non-squamous non small cell lung cancer (NS-NSCLC). A Galician Lung Cancer Group Study.
    Areses Manrique, Ma Carmen
    Fernandez Nunez, Natalia
    Covela Rua, Marta
    Alonso Herrero, Ana
    Villanueva Silva, Maria Jose
    Afonso Afonso, Francisco J.
    Esquerdo, Gaspar
    Campos Balea, Begona
    Lazaro Quintela, Martin
    Garcia Mata, Jesus
    Vazquez-Estevez, Sergio
    Anido Herranz, Urbano
    Casal Rubio, Joaquin
    Firvida Perez, Jose Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)
    Skaff, Z. G.
    Hageboutros, A.
    Krieger, K.
    Coakley, S.
    Somer, R.
    Stevenson, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
  • [40] A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol
    Fujimoto, Nobukazu
    Aoe, Keisuke
    Kozuki, Toshiyuki
    Oze, Isao
    Kato, Katsuya
    Kishimoto, Takumi
    Hotta, Katsuyuki
    CLINICAL LUNG CANCER, 2018, 19 (05) : E705 - E707
12345